Roxane Laboratories, Inc. is a leader in the development, manufacture and marketing of pain control medications designed to relieve the suffering of patients with cancer and HIV infections. The company produces the broadest line of strong, cost-effective, oral opioid analgesics and other quality pain relief products.
Roxane started in 1885 as Columbus Pharmacal, a small, regional pharmaceutical manufacturer and was acquired by Boehringer Ingelheim in 1978. Headquartered in Columbus, Ohio, its 1000 employees work in a modern 500,000 square foot laboratory, manufacturing, and office complex on 72 acres. The commitment of its employees has led Roxane:
In addition to its commitment to offer pain relief to severely ill patients, Roxane is producing a wide range of drugs to aid in heroin and other types of addiction.
Roxane Laboratories, Inc. is a wholly owned subsidiary of Boehringer Ingelheim Corporation, located in Ridgefield, CT, and is part of the Boehringer Ingelheim worldwide group of companies. Boehringer Ingelheim, headquartered in Ingelheim (Germany) ranks among the top 20 pharmaceutical companies in the world. It reported revenues exceeding DM 8.7 billion (US$4.97 billion) in 1998.
The corporation has more than 140 affiliated companies and it conducts business on every continent. Its product range is focused on human pharmaceuticals - hospital, prescription and self-medication - as well as animal health.
The company has substantial research and development, production, and distribution facilities around the globe. In 1998 Boehringer Ingelheim spent an equivalent of 18 % of total sales on R&D.
| Main Page | Department Information | Residency Information |
| Campus Information | Site Directory |